These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32209370)

  • 21. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.
    Kadakia E; Bottino D; Amiji M
    Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
    Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
    Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
    [No Abstract]   [Full Text] [Related]  

  • 23. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model.
    Ahmad N; Ahmad I; Umar S; Iqbal Z; Samim M; Ahmad FJ
    Drug Deliv; 2016 Sep; 23(7):2095-2114. PubMed ID: 25237726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake and Transport of Ultrafine Nanoparticles (Quantum Dots) in the Nasal Mucosa.
    Bejgum BC; Donovan MD
    Mol Pharm; 2021 Jan; 18(1):429-440. PubMed ID: 33346666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
    Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
    Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
    Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
    Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The nasal mucosa permeability and toxicity of baicalin carrier systems liposomes, beta-cyclodextrin inclusion compound, and phospholipid complex].
    Wu PJ; Xu RC; Su ZT; Wei P; Lin YJ; Yang M; Zheng Q
    Yao Xue Xue Bao; 2009 Apr; 44(4):417-24. PubMed ID: 19545062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B; Khunt D; Misra M; Padh H
    Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
    Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
    Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLGA Nanoparticles for Nose to Brain Delivery of Clonazepam: Formulation, Optimization by 32 Factorial Design, In Vitro and In Vivo Evaluation.
    Shah P; Sarolia J; Vyas B; Wagh P; Ankur K; Kumar MA
    Curr Drug Deliv; 2021; 18(6):805-824. PubMed ID: 32640955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
    Jojo GM; Kuppusamy G; De A; Karri VVSNR
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
    Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
    Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a linear dual column HPLC-MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid.
    Yu H; Hong S; Jeong CH; Bae JW; Lee S
    Arch Pharm Res; 2018 Mar; 41(3):288-298. PubMed ID: 29196917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery.
    Kumar NN; Gautam M; Lochhead JJ; Wolak DJ; Ithapu V; Singh V; Thorne RG
    Sci Rep; 2016 Aug; 6():31732. PubMed ID: 27558973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PLA-PEG particles as nasal protein carriers: the influence of the particle size.
    Vila A; Sánchez A; Evora C; Soriano I; McCallion O; Alonso MJ
    Int J Pharm; 2005 Mar; 292(1-2):43-52. PubMed ID: 15725552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems.
    Vazzana M; Andreani T; Fangueiro J; Faggio C; Silva C; Santini A; Garcia ML; Silva AM; Souto EB
    Biomed Pharmacother; 2015 Mar; 70():234-8. PubMed ID: 25776506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
    Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
    Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin.
    Ruan Y; Yao L; Zhang B; Zhang S; Guo J
    Drug Dev Ind Pharm; 2012 Jan; 38(1):123-8. PubMed ID: 21721852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake.
    Musumeci T; Pellitteri R; Spatuzza M; Puglisi G
    J Pharm Sci; 2014 Feb; 103(2):628-35. PubMed ID: 24395679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.